The Form 4 filing was filed on October 30, 2026. It covers sales made on October 28. Form 4 reports changes in an insider's company stock holdings.
Ari P. Kornhaber serves as executive vice president and head of corporate development at Esquire Financial Holdings (ESQ).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-28 |
| Date of Latest Transaction | 2026-10-28 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 20,000 |
| Price | $128.15 |
| Total Transaction Value | $2,563,036.52 |
| Insider | |
| Ticker Symbol | ESQ |
| Company | Esquire Financial Holdings, Inc. |
| Insider Name | Kornhaber Ari P |
| Insider Title | EVP and Head of Corp Dev |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 99,792 |
| Position Size Change | 16.70% |
| Filing | |
| Filing Date | 2026-10-30 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of company shares, reported under transaction code S. The reported activity consists of two sale transactions covered by one filing.
What was the average price of the transaction?
The average sale price was $128.15 per share across the two transactions, rounded to cents. This is the average amount received for each share sold.
How did this transaction affect the insider's holdings?
Ari P. Kornhaber sold 20,000 shares and reported owning 99,792 shares afterward. The shares sold made up 16.70% of the shares he held before these sales. That percentage describes the reduction in his reported share count.
What's the total transaction value?
The two sales had a total value of $2,563,036.52. The reported value before rounding to cents was $2,563,036.5248. This total covers both transactions.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Footnote text was not provided, so any further terms or explanations remain unknown. The available details do not establish why he sold.
For research purposes only; not investment advice.